瑞克·布萊特

**瑞克・亞瑟・布萊特**（英語：Rick Arthur Bright, 1966 年 —）是美國免疫學家和公共衛生官員。

## 生平

布萊特曾於 2016 年至 2020 年 4 月 22 日間任生物醫學高級研究與發展署主任。2020 年 5 月，布萊特宣稱自己早在在 2020 年 1 月就試圖發出有關 2019 冠狀病毒病的警報，但遭到美國衛生及公共服務部助理部長的抵制。後美國總統川普又多次在白宮記者會上推薦羥氯喹藥物，但布萊特認為羥氯喹未被證實有效，不願推廣該藥物，於是被調離崗位，並且自稱 4 月 22 日後再也沒拿到工資。

## 作品

* Bright, Rick Arthur. (學位論文) （英語）.
* Crawford, PC; Dubovi, EJ; Castleman, WL; Stephenson, I; Gibbs, EP; Chen, L; Smith, C; Hill, RC; Ferro, P. Transmission of equine influenza virus to dogs.. Science (New York, N.Y.). 21 October 2005, **310** (5747): 482–5 [2020-05-15]. PMID 16186182. doi:10.1126/SCIENCE.1117950. （原始內容存檔於 2021-03-08）.  Template:Wikidata+icon
* Bright, RA; Shay, DK; Shu, B; Cox, NJ; Klimov, AI. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States.. JAMA. 22 February 2006, **295** (8): 891–4 [2020-05-15]. PMID 16456087. doi:10.1001/JAMA.295.8.JOC60020. （原始內容存檔於 2021-12-01）.  Template:Wikidata+icon
* Bright, Rick A.; Carter, Donald M.; Daniluk, Shannon; Toapanta, Franklin R.; Ahmad, Attiya; Gavrilov, Victor; Massare, Mike; Pushko, Peter; Mytle, Nutan. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Vaccine. May 2007, **25** (19): 3871–3878 [2020-05-15]. PMID 17337102. doi:10.1016/J.VACCINE.2007.01.106. （原始內容存檔於 2020-09-27）.  Template:Wikidata+icon
* Deyde, Varough M.; Xu, Xiyan; Bright, Rick A; Shaw, Michael; Smith, Catherine B.; Zhang, Ye; Shu, Yuelong; Gubareva, Larisa V.; Cox, Nancy J. Surveillance of Resistance to Adamantanes among Influenza A(H3N2) and A(H1N1) Viruses Isolated Worldwide. The Journal of Infectious Diseases. 15 July 2007, **196** (2): 249–257 [2020-05-15]. PMID 17570112. doi:10.1086/518936. （原始內容存檔於 2020-06-10）.  Template:Wikidata+icon
* Bright, Rick A.; Carter, Donald M.; Crevar, Corey J.; Toapanta, Franklin R.; Steckbeck, Jonathan D.; Cole, Kelly S.; Kumar, Niranjan M.; Pushko, Peter; Smith, Gale. Cross-Clade Protective Immune Responses to Influenza Viruses with H5N1 HA and NA Elicited by an Influenza Virus-Like Particle. PLoS ONE. 30 January 2008, **3** (1): e1501 [2022-01-16]. PMC 2200794 . PMID 18231588. doi:10.1371/JOURNAL.PONE.0001501. （原始內容存檔於 2020-09-25）.  Template:Wikidata+icon
* Sheu, Tiffany G.; Deyde, Varough M.; Okomo-Adhiambo, Margaret; Garten, Rebecca J.; Xu, Xiyan; Bright, Rick A.; Butler, Eboneé N.; Wallis, Teresa R.; Klimov, Alexander I. Surveillance for Neuraminidase Inhibitor Resistance among Human Influenza A and B Viruses Circulating Worldwide from 2004 to 2008. Antimicrobial Agents and Chemotherapy. September 2008, **52** (9): 3284–3292 [2020-05-15]. PMC 2533500 . PMID 18625765. doi:10.1128/AAC.00555-08. （原始內容存檔於 2020-12-04）.  Template:Wikidata+icon
* Bright, Rick. Building New Models To Support The Ailing Antibiotics Market. Forbes. 10 May 2019 [2020-05-15]. （原始內容存檔於 2020-11-08） （英語）.
* Bright, Rick. A Newly FDA-Licensed Vaccine for the Prevention of Smallpox. U.S. Department of Health & Human Services. 24 September 2019 [2020-05-15]. （原始內容存檔於 2021-01-17） （英語）.
* Bright, Rick. Read: Statement from leader of federal vaccine agency about his reassignment. CNN. 22 April 2020 [2020-05-15]. （原始內容存檔於 2021-03-11）.

## 參考文獻

## 外部連結

* C-SPAN 內的亮相頁面（英文）
* Scientific Integrity in the COVID-19 Response （頁面存檔備份，存於網際網路檔案館）. Written Testimony to the House Subcommittee on Health, May 14, 2020